The purpose of Core A is to ensure scientific progress by providing adequate scientific and administrative leadership to the program and provide adequate financial oversight. This will be accomplished by extensive review of scientific progress during monthly meetings of all the lab groups and smaller meetings held by subgroups. Scientific direction and research results will be subject to intense, yet constructive, criticism by investigators within the P01, and by an outside advisory board. We strongly believe that our extensive collaborative approach promoted by Core A is unique. Indeed, this program represents the nucleating group for Bay Area investigators studying intracellular pathogens and innate immunity.
The Specific Aims are: 1. Ensure Scientific Progress, and II. Implement Financial Management and Administrative Support. To facilitate interactions among investigators, two-hour joint lab meetings will continue to be held monthly at the UCSF Mission Bay Campus. The monthly meetings consist of introductory discussions, two scientific presentations, and post-meeting discussions. A scientific advisory board will be maintained to oversee research progress and provide objective criticism of the programs. The board will meet once every other year and provide a report. To facilitate interactions between the cores and the projects, each of the labs will designate representative to Core B (mouse and ENU core). A website will help coordinate sharing of data, protocols, and Powerpoint presentations from the monthly meeting. Additional mechanisms to promote interactions include shared interviews of potential post-doctoral fellows and a joint seminar program between UCB and UCSF. Core A will provide the financial oversight for the program project and for each research plan and core. UC Berkeley will act as the central administrator of the program's financial activities. The Administrative Assistant will facilitate communication via the appropriate contacts at UCSF such that UC Berkeley can monitor and expedite financial arrangements and also attend to any problems. Project Leaders will receive monthly reports of their financial activities and have ample opportunities to resolve questions and assess the planning of purchases for their research.
The proposed studies will lead to the characterization of a host system of innate immunity that will lead to vaccines and/or therapeutics to treat disease, with relevance to biodefense, emerging infections and global health.
|Kranzusch, Philip J; Lee, Amy S Y; Wilson, Stephen C et al. (2014) Structure-guided reprogramming of human cGAS dinucleotide linkage specificity. Cell 158:1011-21|
|Burke, Thomas P; Loukitcheva, Anastasia; Zemansky, Jason et al. (2014) Listeria monocytogenes is resistant to lysozyme through the regulation, not the acquisition, of cell wall-modifying enzymes. J Bacteriol 196:3756-67|
|Bécavin, Christophe; Bouchier, Christiane; Lechat, Pierre et al. (2014) Comparison of widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic variations underlying differences in pathogenicity. MBio 5:e00969-14|
|Tenthorey, Jeannette L; Kofoed, Eric M; Daugherty, Matthew D et al. (2014) Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes. Mol Cell 54:17-29|
|Lee, Bettina L; Barton, Gregory M (2014) Trafficking of endosomal Toll-like receptors. Trends Cell Biol 24:360-9|
|Sivick, Kelsey E; Arpaia, Nicholas; Reiner, Gabrielle L et al. (2014) Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies. Cell Host Microbe 15:203-13|
|Archer, Kristina A; Durack, Juliana; Portnoy, Daniel A (2014) STING-dependent type I IFN production inhibits cell-mediated immunity to Listeria monocytogenes. PLoS Pathog 10:e1003861|
|Arpaia, Nicholas; Barton, Gregory M (2013) The impact of Toll-like receptors on bacterial virulence strategies. Curr Opin Microbiol 16:17-22|
|Isaac, Dervla T; Coady, Alison; Van Prooyen, Nancy et al. (2013) The 3-hydroxy-methylglutaryl coenzyme A lyase HCL1 is required for macrophage colonization by human fungal pathogen Histoplasma capsulatum. Infect Immun 81:411-20|
|Aachoui, Youssef; Leaf, Irina A; Hagar, Jon A et al. (2013) Caspase-11 protects against bacteria that escape the vacuole. Science 339:975-8|
Showing the most recent 10 out of 71 publications